[{"address1": "Level 10", "address2": "Tower 11 Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "592000", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.46, "open": 7.38, "dayLow": 6.7501, "dayHigh": 7.4277, "regularMarketPreviousClose": 7.46, "regularMarketOpen": 7.38, "regularMarketDayLow": 6.7501, "regularMarketDayHigh": 7.4277, "payoutRatio": 0.0, "beta": 0.156, "trailingPE": 0.0009995087, "forwardPE": -3.5778894, "volume": 81010, "regularMarketVolume": 81010, "averageVolume": 1885705, "averageVolume10days": 55160, "averageDailyVolume10Day": 55160, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 15941537, "fiftyTwoWeekLow": 3.08, "fiftyTwoWeekHigh": 597.6, "priceToSalesTrailing12Months": 1594.1537, "fiftyDayAverage": 8.3516, "twoHundredDayAverage": 51.5009, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 11679566, "profitMargins": 0.0, "floatShares": 96657, "sharesOutstanding": 2238980, "sharesShort": 64256, "sharesShortPriorMonth": 123114, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0287, "heldPercentInsiders": 0.60157, "heldPercentInstitutions": 0.00795, "shortRatio": 0.01, "shortPercentOfFloat": 0.045, "impliedSharesOutstanding": 2345900, "bookValue": 2.29, "priceToBook": 3.1091702, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -6428000, "trailingEps": 7123.5, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1751846400, "enterpriseToRevenue": 1167.957, "enterpriseToEbitda": -1.128, "52WeekChange": -0.9730303, "SandP52WeekChange": 0.18469036, "lastDividendValue": 0.15, "lastDividendDate": 1745884800, "quoteType": "EQUITY", "currentPrice": 7.12, "recommendationKey": "none", "totalCash": 4275000, "totalCashPerShare": 1.909, "ebitda": -10355000, "totalDebt": 10000, "quickRatio": 5.625, "currentRatio": 5.767, "totalRevenue": 10000, "debtToEquity": 0.275, "revenuePerShare": 0.006, "returnOnAssets": -1.0283101, "returnOnEquity": -2.7680302, "grossProfits": 10000, "freeCashflow": -9424750, "operatingCashflow": -8726000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1035.8, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -4.55764, "regularMarketPrice": 7.12, "marketState": "CLOSED", "firstTradeDateMilliseconds": 1079447400000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.12, "postMarketChange": 0.0, "regularMarketChange": -0.34, "regularMarketDayRange": "6.7501 - 7.4277", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1885705, "fiftyTwoWeekLowChange": 4.04, "fiftyTwoWeekLowChangePercent": 1.3116883, "fiftyTwoWeekRange": "3.08 - 597.6", "fiftyTwoWeekHighChange": -590.48, "fiftyTwoWeekHighChangePercent": -0.9880857, "fiftyTwoWeekChangePercent": -97.30303, "dividendDate": 1746057600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 7123.5, "epsForward": -1.99, "fiftyDayAverageChange": -1.2315998, "fiftyDayAverageChangePercent": -0.14746873, "twoHundredDayAverageChange": -44.3809, "twoHundredDayAverageChangePercent": -0.86175, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "corporateActions": [], "postMarketTime": 1757116580, "regularMarketTime": 1757102401, "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]